Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

A letter from Travenol Laboratories to the DHSS stated that "while the causative agent of [AIDS] remains to be identified, some evidence suggests it is caused by a virus that can be transmitted by blood and certain blood products."

  • Read more about A letter from Travenol Laboratories to the DHSS stated that "while the causative agent of [AIDS] remains to be identified, some evidence suggests it is caused by a virus that can be transmitted by blood and certain blood products."

Ken Fitch wrote to Haemophilia Centre Directors stating that Armour had programmes in operation designed to help prevent the use of plasma obtained from high risk groups associated with AIDS in the production of clotting factor concentrates.

  • Read more about Ken Fitch wrote to Haemophilia Centre Directors stating that Armour had programmes in operation designed to help prevent the use of plasma obtained from high risk groups associated with AIDS in the production of clotting factor concentrates.

Peter Coombes wrote to David Watters enclosing a copy of a Kryobulin data sheet for non heat treated product.

  • Read more about Peter Coombes wrote to David Watters enclosing a copy of a Kryobulin data sheet for non heat treated product.

Travenol Laboratories applied for a product licence for Antihaemophilic Factor (Human) Method Four-Heat Treated Hemofil-T.

  • Read more about Travenol Laboratories applied for a product licence for Antihaemophilic Factor (Human) Method Four-Heat Treated Hemofil-T.

The Committee on Safety of Medicines advised against issuing a product licence for heat-treated Hemofil in September 1983 in part because of the absence of evidence that AIDS was transmitted by a virus and hence might be affected by heat treatment.

  • Read more about The Committee on Safety of Medicines advised against issuing a product licence for heat-treated Hemofil in September 1983 in part because of the absence of evidence that AIDS was transmitted by a virus and hence might be affected by heat treatment.

Dr Evatt and his colleagues "were now convinced that in spite of the absence of an identified agent, the pattern of the epidemiological evidence was sufficient to implicate a blood-borne disease."

  • Read more about Dr Evatt and his colleagues "were now convinced that in spite of the absence of an identified agent, the pattern of the epidemiological evidence was sufficient to implicate a blood-borne disease."

Dr Evatt anticipated that a public meeting to be held at the instigation of the CDC would be a "pro forma stamp for action, that is, review the data, accept the evidence as significantly supporting the case for blood-borne infection and produce recommendations that high-risk groups be excluded from the donor pool and/or adopt a surrogate test."

  • Read more about Dr Evatt anticipated that a public meeting to be held at the instigation of the CDC would be a "pro forma stamp for action, that is, review the data, accept the evidence as significantly supporting the case for blood-borne infection and produce recommendations that high-risk groups be excluded from the donor pool and/or adopt a surrogate test."

Dr Kingdon recorded "we have been closely monitoring the issue at Hyland".

  • Read more about Dr Kingdon recorded "we have been closely monitoring the issue at Hyland".

Dr Kingdon wrote "Many of us have been involved in considering the problem and in discussions with the CDC on its implication for our blood products."

  • Read more about Dr Kingdon wrote "Many of us have been involved in considering the problem and in discussions with the CDC on its implication for our blood products."

It was widely known that gay men in particular were at risk of developing a failure of the immune system, which was indeed called GRIDS (Gay Related Immunodeficiency Syndrome).

  • Read more about It was widely known that gay men in particular were at risk of developing a failure of the immune system, which was indeed called GRIDS (Gay Related Immunodeficiency Syndrome).

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 297
  • Page 298
  • Page 299
  • Page 300
  • Current page 301
  • Page 302
  • Page 303
  • Page 304
  • Page 305
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.